uniQure Announces Dosing of First Patients in Europe Open-Label Trial of AMT-130katie8288Feb 7, 20220 min read
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
Comments